Consumer Defensive
Live Price
Offline$3.12
-0.64% today
1Y Change
+30.13%
Window
Jun 20, 2025 → Jun 4, 2026
Coverage: 240 bars · Jun 20, 2025 → Jun 4, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ambev S.A. (ABEV) is a Consumer Defensive stock with a market cap of $225.53B and listed on NYSE. The stock last traded around $3.12 and up 30.1% across the available one-year price window (Jun 20, 2025 → Jun 4, 2026). Baseline metrics include revenue growth of -1.4%, EPS growth of +7.6%, a dividend yield of 11.8%. What stands out right now is revenue -1.4%, EPS +7.6%, free cash flow -7.0% with operating margin 25.7% and ROIC 18.0%. The dividend matters to the case here, with a current yield around 11.8%. Valuation is more restrained than many high-expectation growth names at P/E 14.5 and price/sales 2.6. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines ABEV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ABEV
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ABEV Max Drawdown
-16.10%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ABEV and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$72.9B
-8.6% YoY
FY Net Income
$12.7B
-12.4% YoY
Free Cash Flow
$15.2B
+7.9% YoY
Revenue Growth
-1.4%
EPS Growth
+7.6%
Gross Margin
50.5%
Net Margin
17.6%
Income statement
BRL
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 88.2B | 89.5B | 79.7B | 79.7B | 72.9B |
| Gross Profit | 45.4B | 45.8B | 40.4B | 39.3B | 37.2B |
| Operating Income | 23.3B | 21.8B | 18.8B | 17.7B | 17.1B |
| EBITDA | 26.3B | 29.0B | 24.3B | 23.1B | 21.0B |
| Net Income | 15.5B | 14.4B | 14.5B | 14.5B | 12.7B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
BRL
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 18.6B | 28.6B | 16.1B | 14.9B | 16.6B |
| Total Assets | 148.1B | 162.5B | 132.6B | 138.0B | 138.6B |
| Total Liabilities | 59.3B | 62.9B | 52.5B | 54.6B | 54.6B |
| Shareholder Equity | 87.9B | 98.6B | 79.0B | 82.0B | 82.6B |
| Total Debt | 5.3B | 3.5B | 3.5B | 3.8B | 3.1B |
| Net Debt | -13.3B | -25.1B | -12.6B | -11.1B | -13.5B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
22.9B
+10.9% YoY
Capital Expenditures
7.7B
-17.5% YoY
Free Cash Flow
15.2B
+7.9% YoY
Key ratios
Gross Margin
50.5%
Operating Margin
25.7%
Net Margin
17.6%
ROE
16.9%
Debt / Equity
0.06x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.